Irfan A. Asangani

University of Pennsylvania · company speakers →

Is this you? Claim this profile →

No public contact links on file.

Speaking history

AACR Drug Discovery and Development (AACR D3)

21 July 2026 Boston, United States “Therapeutic targeting of TMPRSS2 and ACE2 as a potential strategy to combat COVID-19”

Advances in Malignant Lymphoma: From Discovery to Clinical Impact

24 June 2026 Philadelphia, United States “Therapeutic targeting of TMPRSS2 and ACE2 as a potential strategy to combat COVID-19”

AACR Special Conference: Breaking Barriers in the Fight Against Rare Cancers

18 July 2026 Vancouver, Canada “Therapeutic targeting of TMPRSS2 and ACE2 as a potential strategy to combat COVID-19”

Sourcing speakers for your event?

Browse the speaker directory →